Participated · Equity · Mar 2019

Learning to Sleep offers a digital, drug-free sleep treatment platform delivering a five-week CBT programme that patients can access without waiting. The company has treated over 1,000 patients in Sweden and Norway and reports that 94% of participants benefit and all were able to stop taking sleeping pills. It is a registered care provider in Sweden; its treatment is approved by Läkemedelsverket and is CE marked. The startup plans to consolidate its position in the Swedish market and to launch its product in the UK. Management says the funding will be used in part for market access, supporting wider patient reach across Europe. The company emphasizes prevention of sleeping drug use as part of its public-health impact.